Alcon Finance BV, founded in 2017 and headquartered in Amsterdam, serves as the financing arm for Alcon, Inc., a global leader in eye care. The company is dedicated to providing innovative products and services that enhance vision and improve quality of life for patients worldwide.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| ALCSW 2.38% 2028-05-31 EURAlcon Finance BV | Switzerland | 2028-05-31 | 2.375 | 2.54 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Alcon Finance BV has actively participated in the bond market, issuing its first bonds in 2018 to support corporate growth initiatives. Notably, their €500 million issuance in 2021 was part of a strategic refinancing effort, showcasing their strong commitment to maintaining favorable capital structures. Current yields on their bonds are competitive within the healthcare sector, reflecting investor confidence and the robustness of their financial strategies. Alcon Finance BV bonds often feature callable options, offering investors flexibility amid changing interest rate environments.